SA
GMAB logo
Genmab A/S(GMAB)
Closing price · checked 8:25 PM ETAbout this dataData status
$50.60▼-0.75 (-1.46%)
Extended:$50.02-0.58 (-1.15%)· 8:25 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 35.9 · very high volatility

Overview →
Next report

Feb 16 2027in 86 days

EPS estimate

$0.23

Revenue estimate

$1.25B

EPS beats

8 of last 12

Earnings SurpriseEPS, actual vs estimateLatest +55.6%

How far reported EPS beat (+) or missed (−) the analyst estimate that stood when each report landed.

2024: 0.0%2024: -24.1%2024: -17.1%2025: 58.3%2025: 34.8%2025: 38.5%2025: 35.4%2026: -89.1%2026: -42.0%2026: 45.9%2026: 55.6%0.0%-17.1%34.8%35.4%-42.0%55.6%
May 2 2024Nov 5 2026
ReportedEPS estEPS actualSurpriseRevenue estRevenue actualSurprise
Nov 5 2026$0.36$0.56+55.6%$1.20B$1.19B-0.9%
Aug 6 2026$0.37$0.54+45.9%$1.12B$1.16B+3.5%
May 7 2026$0.15$0.09-42.0%$906M$896M-1.1%
Feb 17 2026$0.46$0.05-89.1%$1.07B$1.06B-0.8%
Nov 6 2025$0.48$0.65+35.4%$1.01B$1.02B+1.1%
Aug 7 2025$0.39$0.54+38.5%$953M$925M-2.9%
May 8 2025$0.23$0.31+34.8%$755M$726M-3.9%
Feb 12 2025$0.36$0.57+58.3%$895M$896M+0.1%
Nov 6 2024$0.35$0.29-17.1%$810M$815M+0.7%
Aug 8 2024$0.29$0.22-24.1%$732M$790M+7.8%
May 2 2024$0.16$0.16+0.0%$572M$598M+4.6%
Feb 14 2024$0.34$0.36+5.9%$671M$675M+0.6%

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+21.22%
EPS+27.85%
FY2028
Rev+27.79%
EPS+67.24%
FY2029
Rev+11.78%
EPS+16.06%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
MetricFY2026EFY2027EFY2028EFY2029EFY2030E
Revenue Avg$4.47B$5.42B$6.93B$7.75B$8.63B
Low$4.46B$5.19B$6.07B$7.41B$8.25B
High$4.50B$5.70B$8.23B$8.37B$9.33B
EBITDA Avg$1.23B$1.39B$2.60B$2.63B$3.06B
Low$994M$1.29B$1.19B$2.49B$2.90B
High$1.27B$1.49B$2.82B$2.88B$3.37B
EBIT Avg$1.16B$1.31B$2.51B$2.53B$2.95B
Low$920M$1.21B$1.10B$2.39B$2.79B
High$1.20B$1.42B$2.73B$2.78B$3.26B
Net Income Avg$862M$985M$1.94B$1.95B$2.29B
Low$675M$903M$817M$1.84B$2.16B
High$896M$1.07B$2.11B$2.15B$2.53B
EPS Avg$1.25$1.60$2.68$3.11$3.65
Low$1.08$1.44$1.30$2.93$3.44
High$1.43$1.70$3.37$3.44$4.03
Analysts (Rev / EPS)13 / 913 / 916 / 1414 / 714 / 11
Quarterly
MetricQ4 2026Q1 2027Q2 2027Q3 2027Q4 2027Q1 2028Q2 2028Q3 2028
Revenue Avg$1.25B$1.11B$1.32B$1.43B$1.59B$1.46B$1.78B$1.94B
Low$1.24B$1.04B$1.26B$1.37B$1.52B$1.40B$1.70B$1.86B
High$1.28B$1.16B$1.38B$1.50B$1.66B$1.53B$1.86B$2.03B
EBITDA Avg$304M$291M$447M$497M$567M$492M$711M$802M
Low$188M$226M$431M$477M$543M$473M$680M$766M
High$383M$357M$466M$519M$593M$514M$746M$842M
EBIT Avg$277M$265M$421M$470M$540M$466M$684M$774M
Low$162M$199M$404M$451M$517M$446M$653M$738M
High$356M$331M$440M$492M$566M$487M$719M$814M
Net Income Avg$131M$122M$246M$285M$340M$281M$455M$526M
Low$40M$70M$232M$270M$322M$266M$430M$498M
High$194M$174M$261M$302M$361M$298M$482M$558M
EPS Avg$0.21$0.20$0.40$0.46$0.55$0.45$0.73$0.85
Low$0.06$0.11$0.37$0.43$0.52$0.43$0.69$0.80
High$0.31$0.28$0.42$0.49$0.58$0.48$0.78$0.90
Analysts (Rev / EPS)7 / 53 / 31 / 11 / 11 / 11 / 21 / 21 / 2

Q3 2026
Checking for summary...

Last reported Earnings history refreshes daily; a new report appears within about 2 daysAbout this data

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.